Login

Abbott India Ltd.

₹35670.0

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Abbott India Ltd.

₹35670.0

₹35670.0

730.0 (2.09%) - 30 Jun 2025 04:28 PM

About Company

Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories, offers high-quality trusted medicines in multiple therapeutic categories such as women’s health, gastroenterology, cardiology, metabolic disorders and primary care. It is one of India's fastest-growing pharmaceutical companies. It has expertise across product development, manufacturing, sales and customer service and are dedicated to providing high-quality, reliable products with the expert clinical support its customers need. The company’s in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market.

Market Cap. ₹ 75,796 Cr.
52 Week - High/Low ₹ 37,000/25,325
P/E Ratio 52.49
P/B Ratio 20.07
Enterprise Value ₹ 73,961 Cr.
ROE % 35.31
RSI Value 84.70
EMA 50 31291.01
EMA 200 29581.77
Market Cap. ₹ 75,796 Cr.
52 Week - High/Low ₹ 37,000/25,325
P/E Ratio N/A
P/B Ratio N/A
Enterprise Value ₹ 74,246 Cr.
ROE % 37.45
RSI Value 84.70
EMA 50 31291.01
EMA 200 29581.77
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.